NDC 80425-0144-01 - Tizanidine HCL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0144
- Requested NDC
- 80425-0144-01
- Package NDCs from labels
- 80425-0144-3, 80425-0144-2, 80425-0144-1, 80425-0144-4, 80425-0144-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-11-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tizanidine HCL - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-11-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0144-1 | Tizanidine HCL | 30 in 1 BOTTLE | CAPSULE | 30 | 9 | |
| 80425-0144-2 | Tizanidine HCL | 60 in 1 BOTTLE | CAPSULE | 60 | 9 | |
| 80425-0144-3 | Tizanidine HCL | 90 in 1 BOTTLE | CAPSULE | 90 | 9 | |
| 80425-0144-4 | Tizanidine HCL | 120 in 1 BOTTLE | CAPSULE | 120 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0144 | TIZANIDINE HCL CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250101_c46c7aa3-69db-82dc-e053-2995a90ac251.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0144-1 | EA - Each | 80425-0144 | b99d8b6e-963c-4879-8b61-3267b63e9b19 | 1 | 2023-06-06 |
| 80425-0144-2 | EA - Each | 80425-0144 | 2c88d83a-8c4b-4926-80b5-8419ee8e0ed4 | 1 | 2023-06-06 |
| 80425-0144-3 | EA - Each | 80425-0144 | 4ef89d59-832a-4d98-ae18-e74972a19a02 | 1 | 2023-06-06 |
| 80425-0144-4 | EA - Each | 80425-0144 | 35e993ff-b889-457e-a09e-a02fbef0a6ca | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tizanidine | TIZANIDINE | Northwind Health Company, LLC | da31fbeb-3781-5e75-e053-2a95a90adb73 | 2026-01-01 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidne hydrochloride | TIZANIDNE HYDROCHLORIDE | Ascend Laboratories, LLC | d7c97b79-da59-4e86-a01b-f91046d04f74 | 2025-12-23 | Warnings, Adverse reactions | ANDA212196 67877-611 485485 485486 485484 628c23e5-c9ed-453b-a83e-1514d6b02912 d7c97b79-da59-4e86-a01b-f91046d04f74 B53E3NMY5C |
| Tizanidine Hydrochloride | TIZANIDINE HYDROCHLORIDE | Asclemed USA, Inc. | 07b8db58-d037-477e-a62f-025e8a5afcb4 | 2025-12-18 | Warnings, Adverse reactions | ANDA212196 485485 485486 485484 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Zydus Lifesciences Limited | 5f4889d1-1387-4c90-9b76-00beda3c1683 | 2025-12-15 | Warnings, Adverse reactions | 485485 485486 485484 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 146c853c-99a8-4bf3-b1e3-be6876abe6ff | 2025-12-10 | Warnings, Adverse reactions | 485485 485486 485484 B53E3NMY5C |
| Tizanidine HCL | TIZANIDINE HCL | Advanced Rx of Tennessee, LLC | b353cdb8-75fa-7e3c-e053-2a95a90ada58 | 2025-12-05 | Warnings, Adverse reactions | 485485 B53E3NMY5C |
| Tizanidine HCl | TIZANIDINE HCL | Advanced Rx Pharmacy of Tennessee, LLC | afc90292-c6bf-2d96-e053-2995a90abf00 | 2025-12-03 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine HCL | TIZANIDINE HCL | Advanced Rx Pharmacy of Tennessee, LLC | c46c7aa3-69db-82dc-e053-2995a90ac251 | 2025-11-17 | Warnings, Adverse reactions | ANDA212196 80425-0144-3 80425-0144-4 80425-0144-1 80425-0144-2 80425-0144 80425014401 485485 43cfb518-01fc-0ea4-e063-6394a90a06d3 c46c7aa3-69db-82dc-e053-2995a90ac251 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2c2bdad9-74a5-8508-e063-6294a90aac7f | 2025-11-17 | Warnings, Adverse reactions | 485485 B53E3NMY5C |
| Tizanidine Hydrochloride | TIZANIDINE HYDROCHLORIDE | AvKARE | acc8f9f6-ceb6-0505-8f11-fd7e1f105af3 | 2025-10-28 | Warnings, Adverse reactions | 485485 485486 485484 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Bryant Ranch Prepack | 9d127a0b-b182-4c8a-91a3-311cc936fd4c | 2025-10-28 | Warnings, Adverse reactions | 485484 B53E3NMY5C |
| Ontralfy | TIZANIDINE HYDROCHLORIDE | Rosemont Pharmaceuticals, LLC | 7b88c338-c0b7-4c08-bef6-a4ffc2f25df7 | 2025-10-25 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | A-S Medication Solutions | 52830423-0430-410e-93af-169dc11b3565 | 2025-10-17 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fd16a25c-67b6-ae6c-e053-6394a90aeee0 | 2025-10-09 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fdf4f09d-4537-a438-e053-6394a90a573d | 2025-10-09 | Warnings, Adverse reactions | B53E3NMY5C |
| Zanaflex | TIZANIDINE HYDROCHLORIDE | Trifluent Pharma, LLC | 9833a1b8-f530-4a06-bc77-7d11b6e94c65 | 2025-09-30 | Warnings, Adverse reactions | B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 4009c6cb-c183-2165-e063-6294a90aed78 | 2025-09-30 | Warnings, Adverse reactions | 485484 B53E3NMY5C |
| tizanidine | TIZANIDINE | Viona Pharmaceuticals Inc | 8ac00d59-bb80-4530-afe7-90e04a2130b2 | 2025-08-26 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | Direct_Rx | 0bdc188d-b895-acbc-e063-6294a90acd68 | 2025-08-19 | Warnings, Adverse reactions | 485484 B53E3NMY5C |
| tizanidine | TIZANIDINE | Rising Pharma Holdings, Inc. | 433ac98f-ac22-44ad-a8b4-5db5560b9d0f | 2025-08-14 | Warnings, Adverse reactions | B53E3NMY5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.